Pharm Wk6 - Asthma Flashcards

1
Q

What is asthma?

A

A chronic inflammatory disease of the airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What mediators are released by mast cell activation in asthma?

A

Bronchoconstrictor mediators such as:
* Histamine
* Leukotriene D4
* Prostaglandin D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the consequences of bronchoconstrictor mediator release?

A

Leads to:
* Smooth muscle contraction
* Vasodilation
* Microvascular leakage
* Plasma exudation
* Mucus hypersecretion
* Activation of sensory nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the long-term effect of chronic inflammation in asthma?

A

Irreversible fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

At what age is asthma typically diagnosed?

A

In childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Is adult-onset asthma a possibility?

A

Yes, adult-onset asthma does exist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How have pharmaceutical standards for asthma treatment changed?

A

They have been converging for children and adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the goal of asthma therapy for infants and children?

A

To prevent cough, wheeze, or shortness of breath that interferes with:
* Daytime activities
* Exercise
* School attendance
* Growth and development
* Sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a key goal regarding exacerbations for infants and children with asthma?

A

Prevent exacerbations requiring emergency room visits, hospitalizations, or systemic corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the target for the use of short-acting beta2-agonists (SABAs) in children?

A

To reduce to ≤2 doses/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What pulmonary function measure should be achieved in children capable of performing tests?

A

Normal measures of pulmonary function, e.g., forced expiratory volume in 1 second (FEV1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What should be avoided to minimize medication side effects in children?

A

Interference with normal growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a primary goal of asthma therapy for adults?

A

Prevent asthma-related mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What should be maintained for adults with asthma?

A

Asthma control and normal activity levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the goal for daytime symptoms in adults with asthma?

A

Goal: ≤twice/week for symptoms such as cough, wheeze, dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the goal for nocturnal symptoms in adults with asthma?

A

Goal: none for night waking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the goal for the need for reliever therapy in adults?

A

Goal: ≤twice/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is essential for optimal asthma management in adults?

A

Provide optimal pharmacotherapy and avoid adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are inhaled corticosteroids primarily used for?

A

Long-term asthma control

Inhaled corticosteroids are the mainstay for managing asthma over the long term.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do inhaled corticosteroids work at the genetic level?

A

They alter the transcription of many genes

This includes increasing transcription of β2 adrenergic receptor and anti-inflammatory cytokines while decreasing proinflammatory cytokines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What effect do inhaled corticosteroids have on proinflammatory cells?

A

Induce apoptosis

This helps reduce inflammation in the airways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Do inhaled corticosteroids directly affect mast cells?

A

No

Many mast cell mediators are performed, so the effect is indirect over time due to overall muting of the inflammatory response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the effect of inhaled corticosteroids on vascular permeability?

A

Reduce it

This leads to decreased airway edema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What modification is commonly made to inhaled corticosteroids to reduce systemic exposure?

A

Increasing susceptibility to first-pass effect or using a prodrug version

For example, ciclesonide is activated by lung esterases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is an example of an inhaled corticosteroid that is extensively metabolized?

A

Budesonide

It has a bioavailability of around 10% due to metabolism by CYP3A4.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are common adverse effects of inhaled corticosteroids?

A

Sore mouth, sore throat, dysphonia, oral thrush

Risk of oral thrush can be reduced by rinsing the mouth after use or using a spacer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How does long-term use of high doses of inhaled corticosteroids affect children?

A

Associated with an initial decrease in growth rate

This minimally affects adult height, resulting in a 1-2.5 cm reduction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is recommended for adults using high doses of inhaled corticosteroids?

A

Bone densitometry

This is suggested for those with risk factors for osteoporosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the mechanism of action for inhaled beta2-agonists?

A

Activate β2 adrenergic receptors to increase cAMP

cAMP activates protein kinase A, leading to muscle relaxation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What distinguishes short-acting from long-acting beta2-agonists?

A

Duration of bronchodilator effect

Short-acting options are for immediate relief, while long-acting options provide prolonged control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the recommendation for using short-acting beta2-agonists?

A

Only as reliever therapy in combination with low-dose daily inhaled corticosteroid

Monotherapy is no longer recommended due to increased risks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What should long-acting beta2-agonists be used in conjunction with?

A

Inhaled corticosteroids

They should not be used alone due to safety concerns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Which long-acting beta2-agonist has a slow onset and should not be used for immediate relief?

A

Salmeterol

It is important to note the difference in onset times between long-acting options.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What can indicate suboptimal long-term control in asthma management?

A

Use of short-acting options more than 2 times per week

This suggests that the underlying asthma is not adequately controlled.

35
Q

How can short-acting agents help prevent exercise-induced bronchospasm?

A

Used 5-10 minutes before exercise

They can provide protection for up to 2-4 hours.

36
Q

What are common adverse effects of beta2-agonists?

A

Tachycardia, palpitations, nervousness, tremor, hypokalemia, restlessness, dizziness, headache, nausea

These effects can vary based on the agent used.

37
Q

Fill in the blank: Long-acting options are not to be used as _______.

A

monotherapy

This is critical to ensure safety and efficacy in asthma management.

38
Q

What do anticholinergics bind to and block?

A

M3 receptors and block cholinergic stimulation from the vagus nerve

39
Q

What is the primary mechanism of action for anticholinergics?

A

Blocks the rise in intracellular calcium and prevents bronchoconstriction

40
Q

What type of antagonist is Ipratropium?

A

Short-acting muscarinic antagonist

41
Q

How can Ipratropium be used in asthma management?

A

As an add-on therapy to beta2-agonists for management of acute asthma exacerbations

42
Q

What is a useful alternative for patients susceptible to tremor or tachycardia from beta2-agonists?

A

Anticholinergics

43
Q

How does the onset of action for anticholinergics compare to beta2-agonists?

A

Delayed onset of action, but the bronchodilator effect lasts longer

44
Q

In what situation may anticholinergics be useful?

A

In beta-blocker–induced bronchospasm

45
Q

What type of antagonist is Tiotropium?

A

Long-acting muscarinic antagonist

46
Q

What is the dosing frequency for Tiotropium?

A

Once-daily

47
Q

What benefit does Tiotropium provide in asthma therapy?

A

Improves lung function and decreases exacerbations as an add-on therapy

48
Q

What is Ipratropium considered in pediatric patients with severe acute exacerbations?

A

Adjunctive therapy

49
Q

Is Tiotropium approved for use in children in Canada?

A

No, but sometimes used as add-on therapy in children over age 6 with a history of exacerbations

50
Q

What are common adverse effects of anticholinergics?

A

Dry mouth, metallic taste

51
Q

What ocular side effects can occur if anticholinergics are released into the eye?

A

Mydriasis and glaucoma

52
Q

What triggers the release of arachidonic acid in asthma?

A

Asthma triggers such as antigens, cold air, exercise, cytokines

53
Q

What enzyme converts arachidonic acid to leukotriene A4 (LTA4)?

A

5-lipoxygenase

54
Q

What is Montelukast classified as in asthma therapy?

A

Second-line add-on therapy

55
Q

What combination is more effective than combining an inhaled corticosteroid and a leukotriene receptor antagonist?

A

Inhaled corticosteroid/long-acting beta-agonist combination

56
Q

When may leukotriene receptor antagonists be used in children?

A

When corticosteroids fail to control symptoms or cannot be used

57
Q

What are the common adverse effects of leukotriene receptor antagonists?

A

Headache, abdominal pain, flu-like symptoms, hepatotoxicity (rare)

58
Q

What warning has been issued regarding leukotriene receptor antagonists?

A

Boxed warning for neuropsychiatric effects

59
Q

What are biologics used for in asthma treatment?

A

As an adjunct in the treatment of severe, uncontrolled asthma

60
Q

What improvements may biologics provide in asthma patients?

A

Symptom control, FEV1, frequency of exacerbations, and/or reduce oral corticosteroid exposure

61
Q

What is the consensus regarding the use of biologics in pediatric patients?

A

More studies are needed to indicate the benefit, especially in those <12 years of age

62
Q

What is Omalizumab indicated for?

A

Children ≥6 years and adults with moderate to severe asthma inadequately controlled with inhaled corticosteroids and evidence of allergic IgE-mediated asthma

Evidence includes a positive skin prick test or other objective determination.

63
Q

What are the common adverse effects of Omalizumab?

A
  • Injection site reactions (45%)
  • Viral infections (24%)
  • Upper respiratory tract infections (19%)
  • Headache (15%)
  • Sinusitis (16%)
  • Pharyngitis (10%)

These percentages represent the frequency of reported adverse effects.

64
Q

What role does IL5 play in allergic disease?

A

IL5 plays a key role in the generation and survival of eosinophils

Eosinophils are important in the pathophysiology of allergic diseases.

65
Q

Who is Mepolizumab indicated for?

A

Patients ≥6 years with severe eosinophilic asthma inadequately controlled with medium-to-high-dose inhaled corticosteroids and additional asthma controllers

Patients must have a blood eosinophil count ≥300 cells/µL in the past 12 months for children and adolescents or ≥150 cells/µL in adults.

66
Q

What are the adverse effects of Mepolizumab?

A
  • Headache
  • Nasal congestion
  • Pharyngitis
  • Injection site reactions (pain, erythema, swelling, itching)
  • Malignancy (rare)
  • Hypersensitivity reactions (rare)

Hypersensitivity reactions can occur within hours or days of treatment.

67
Q

What symptoms may indicate hypersensitivity reactions to Mepolizumab?

A
  • Swelling of the face, mouth, and tongue
  • Fainting
  • Dizziness
  • Hives
  • Breathing problems
  • Rash

These symptoms require immediate medical attention.

68
Q

What is Dupilumab indicated for?

A

Add-on therapy in patients ≥6 years with severe asthma or atopic dermatitis

Dupilumab targets IL4 and IL13, which are involved in allergic inflammation.

69
Q

What are the common adverse effects of Dupilumab?

A
  • Injection site reactions (14–18%)
  • Oropharyngeal pain (2%)
  • Eosinophilia (2%)
  • Arthralgia
  • Hypersensitivity

These percentages reflect the frequency of adverse effects associated with Dupilumab.

70
Q

What is the first step in using a metered-dose inhaler?

A

Shake the inhaler for 10 seconds

71
Q

What should you do before putting the inhaler mouthpiece in your mouth?

A

Take the cap off the inhaler and make sure it is clean and there is nothing inside of the mouthpiece

72
Q

What is the correct way to breathe while using a metered-dose inhaler?

A

Breathe in deep and steady

73
Q

How long should you hold your breath after inhaling from the inhaler?

A

10 seconds

74
Q

What should you do if you need another puff of medicine after using the inhaler?

A

Wait 1 minute and repeat steps 3-6

75
Q

What should you do after using the inhaler?

A

Rinse with water and spit it out

76
Q

Does pregnancy affect asthma in a predictable manner?

A

No, pregnancy does not affect asthma in any predictable manner

77
Q

What are some outcomes associated with inadequate control of asthma during pregnancy?

A
  • Preterm birth
  • Low birth weight
  • Congenital anomalies
  • Pre-eclampsia
  • Placenta previa
78
Q

What is associated with a normal outcome for asthma during pregnancy?

A

Good control of asthma

79
Q

What types of medications are considered safe for use in pregnancy?

A
  • Inhaled corticosteroids
  • Beta2-adrenergic receptor agonists
  • LABAs
80
Q

What has not shown adverse effects when used during pregnancy?

81
Q

Is there a lot of published data on the effectiveness and safety of biologic therapies during pregnancy?

A

No, there is little published data

82
Q

Does breastfeeding have any known effect on the severity of asthma?

A

No, breastfeeding has no known effect

83
Q

What types of asthma medications are considered safe for breastfeeding patients?

A
  • Bronchodilators (short- and long-acting beta2-agonists and muscarinic antagonists)
  • Inhaled corticosteroids
  • Oral corticosteroids
84
Q

Is there published data on the effectiveness and safety of biologic therapies in breastfeeding?

A

No, there is a lack of published data